Comments on Interim Guidelines for Examination of Patent Applications under the 35 U.S.C. 112 "Written Description" Requirement
Comments on Interim Guidelines for Examination of Patent Applications under the 35 U.S.C. 112 "Written Description" Requirement
- Howard B. Barnaby for New YorK Intellectual Property Assoc.
- Iver P. Cooper
- Melvyn M. Kassenoff
- Gordon Kit
- Lawrence M. Lavin, Jr.
- Robert Marchick for the U.S. Dept of Energy
- Kate H. Murashige
- Harris A. Pitlick
- Eric S. Spector
- Jack Spiegel for the National Institutes of Health [1.1MB]
- Jack Spiegel for the National Institutes of Health (second submission) [350kB]
- John D. Vandenberg
- Harold Varmus
- Valerie Vreeland
- William Watkins
- William Moore [320kB]
- Tim Roberts for the Chartered Institute of Patent Agents, London
- Jill B. Valentine for the Trademarks, Patents and Designs Federation
- Joy L. Bryant for the National Association of Patent Practitioners [340kB]
- Richard Parry for the U.S. Dept. of Agric., Agric. Res. Service
- David Schmickel for the Biotechnology Industry Organization
- Herbert H. Jervis for Pioneer Hi-Bred International
- Richard Shear for Monsanto
- Thomas Webster for Eli Lilly
- U.S. Patent and Trademark Office Society
- Toshimichi Moriya for the Japanese Patent Office
- Terence A. Feuerborn for the University of California
- Genentech, Inc. [500kB]
- A.I.P.L.A. [290kB]
- Oral Hearing Public Comments [2.6MB]
